Brief: ABVC Biopharma Receives Notice Of Allowance From US Patent And Trademark Office For Abv-1504
Nov 7 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FROM US PATENT
AND
TRADEMARK OFFICE FOR ABV-1504 USED TO TREAT MAJOR DEPRESSIVE
DISORDER (MDD)
Source text for Eikon: ID:nGNX1MdCXG
Further company coverage: ABVC.O
((reuters.briefs@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21
NASDAQ RESUMED AT 09:05 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:43 PM
Brief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon